The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-1 antibody pembrolizumab administered at non-standard frequency in non-small cell lung cancer (NSCLC).
 
Kartik Sehgal
No Relationships to Disclose
 
Meghan Shea
No Relationships to Disclose
 
Danielle M. McDonald
No Relationships to Disclose
 
Mark Huberman
No Relationships to Disclose
 
Glen J. Weiss
Employment - Former: Western Regional Medical Center
Stock and Other Ownership Interests - Circulogene Theranostics
Consulting or Advisory Role - Angiex; Circulogene Theranostics; Gerson Lehrman Group; Guidepoint Global; Idea Pharma; Paradigm; Viomics
Speakers' Bureau - Ignyta; Pfizer
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Tesaro
Other Relationship - Arizona Medical Board
 
Paul A VanderLaan
Consulting or Advisory Role - Foundation Medicine; Gala Therapeutics
 
Daniel Botelho Costa
Honoraria - Pfizer; Takeda/Millennium
Consulting or Advisory Role - AstraZeneca; Takeda/Millennium
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck (Inst); Merrimack (Inst); Pfizer (Inst); Takeda/Millennium (Inst)
 
Deepa Rangachari
Consulting or Advisory Role - Advance Medical; DynaMed